Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
31.39
+0.29 (0.93%)
Sep 4, 2026, 3:00 PM CST
SHA:688314 Revenue
Kontour (Xi'an) Medical Technology had revenue of 97.28M CNY in the quarter ending June 30, 2026, with 10.77% growth. This brings the company's revenue in the last twelve months to 351.72M, up 3.78% year-over-year. In the year 2025, Kontour (Xi'an) Medical Technology had annual revenue of 351.08M with 9.05% growth.
Revenue (ttm)
351.72M
Revenue Growth
+3.78%
P/S Ratio
7.18
Revenue / Employee
925.59K
Employees
380
Market Cap
2.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 351.08M | 29.13M | 9.05% |
| Dec 31, 2024 | 321.95M | 46.92M | 17.06% |
| Dec 31, 2023 | 275.03M | 35.08M | 14.62% |
| Dec 31, 2022 | 239.95M | 27.40M | 12.89% |
| Dec 31, 2021 | 212.55M | 48.47M | 29.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Dirui Industrial | 864.90M |
| Chison Medical Technologies | 441.10M |
| Tellgen | 392.11M |
| Jiangsu Canopus Wisdom Medical Technology | 384.50M |
| Nanjing Medlander Medical Technology | 383.30M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 359.10M |
| Beijing Leadman Biochemistry | 317.79M |